Nephros, Inc., out of River Edge, New Jersey, received FDA approval for the firm’s Dual Stage Ultrafilter system. The device is designed to provide redundant filtration for purifying of dialysate fluid and bicarbonate solution.
From the product page:
The Nephros DSU has a 0.005 micron filter pore size designed to remove a broad spectrum of bacteria, viral agents and biological toxins. These toxins include salmonella, hepatitis, HIV, Ebola viruses, legionella, fungi and e-coli. The DSU removes these harmful substances more effectively than other microwater filters currently on the market.
The Nephros DSU’s unique design and materials ensure high flow rates and long life. The true redundant design provides the highest confidence in filter integrity and performance. The Nephros DSU is a truly cost effective, simple and compact means to reliably produce on-site ultrapure water where you need it, when you need it.
Product page: Dual Stage Ultrafilter…
Nephros DSU brochure…
Press release: Nephros Receives 510k Approval for Dual Stage Ultrafilters…